ARCHIVES

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

Boyd’s Rebuttal to DePinho’s Letter to the AAUP

May 30, 2014

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

October 28, 1977

American cancer Society Funds 84 Research Grants. NCI, NIGMS To Support Synchrotron Beamlines.

November 16, 2001

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010